人福医药
(600079)
| 流通市值：367.28亿 | | | 总市值：388.47亿 |
| 流通股本：15.43亿 | | | 总股本：16.32亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,843,946,765.2 | 3,554,890,765.94 | 3,536,453,549.53 | 4,104,912,808.59 |
| 衍生金融资产 | 6,229,076.03 | 8,439,674.58 | 9,210,286.63 | 8,763,767.8 |
| 应收票据及应收账款 | 9,820,834,269.61 | 9,462,627,285.88 | 9,381,142,276.38 | 8,209,871,089.22 |
| 其中：应收票据 | 80,440,880.75 | 89,343,142.04 | 75,911,971.24 | 96,075,065 |
| 应收账款 | 9,740,393,388.86 | 9,373,284,143.84 | 9,305,230,305.14 | 8,113,796,024.22 |
| 应收款项融资 | 793,523,974.52 | 937,740,567.26 | 869,285,240.41 | 1,350,098,658.62 |
| 预付款项 | 545,483,503.99 | 618,394,315.75 | 786,328,026.78 | 721,239,130.66 |
| 其他应收款合计 | 405,467,774.39 | 454,220,645.74 | 502,831,781.16 | 503,201,650.31 |
| 存货 | 3,922,531,611.8 | 3,878,475,974.29 | 3,807,198,317.44 | 3,618,944,898.62 |
| 其他流动资产 | 230,244,291.25 | 229,839,540.17 | 184,380,392.25 | 182,073,592.5 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 20,487,118,563.49 | 20,071,470,540.7 | 20,001,986,929.3 | 19,635,030,670.67 |
| 非流动资产: | | | | |
| 长期应收款 | 381,768,052.39 | 400,925,552.39 | 352,634,102.39 | 364,355,797.05 |
| 长期股权投资 | 1,107,418,683.91 | 1,100,500,484.67 | 1,108,935,965.28 | 1,085,614,045.66 |
| 其他权益工具投资 | 739,489,441.5 | 452,584,567.2 | 555,393,835.47 | 586,305,882.87 |
| 固定资产 | 8,738,522,191.19 | 8,714,971,967.4 | 8,466,982,015.13 | 8,592,189,539.09 |
| 在建工程 | 1,753,207,126.83 | 1,776,575,312.69 | 2,052,694,449.32 | 1,833,883,886.45 |
| 使用权资产 | 53,806,104.64 | 57,161,554.28 | 60,353,907.72 | 59,766,522.58 |
| 无形资产 | 2,026,635,361.04 | 2,043,337,696.33 | 2,046,260,756.18 | 1,914,828,394.93 |
| 开发支出 | 648,394,403.26 | 641,388,152.85 | 657,761,631.87 | 669,002,039.21 |
| 商誉 | 948,043,223.17 | 948,326,301.45 | 948,250,908.74 | 948,221,747.41 |
| 长期待摊费用 | 30,535,875.82 | 32,024,692.1 | 32,311,651.98 | 34,618,138.38 |
| 递延所得税资产 | 79,985,277.87 | 89,028,651.53 | 89,229,366.21 | 86,887,980.54 |
| 其他非流动资产 | 351,010,177.77 | 252,521,196.25 | 407,759,890.26 | 393,592,922.35 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 16,858,815,919.39 | 16,509,346,129.14 | 16,778,568,480.55 | 16,569,266,896.52 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 37,345,934,482.88 | 36,580,816,669.84 | 36,780,555,409.85 | 36,204,297,567.19 |
| 流动负债: | | | | |
| 短期借款 | 7,059,777,209.33 | 7,057,714,715.58 | 7,024,758,103.15 | 6,712,996,875.37 |
| 应付票据及应付账款 | 3,103,074,218.41 | 3,037,093,834.23 | 3,414,742,732.94 | 3,212,732,424.5 |
| 其中：应付票据 | 256,760,444.65 | 233,598,081.67 | 378,172,513.64 | 495,241,203.79 |
| 应付账款 | 2,846,313,773.76 | 2,803,495,752.56 | 3,036,570,219.3 | 2,717,491,220.71 |
| 预收款项 | 5,800,150.14 | 700,150.14 | 700,150.14 | 700,150.14 |
| 合同负债 | 379,996,004.82 | 396,130,935.91 | 365,833,460.96 | 422,848,329.32 |
| 应付职工薪酬 | 286,776,511.45 | 321,514,106.34 | 281,340,713.35 | 395,263,983.52 |
| 应交税费 | 388,064,899.86 | 357,436,316.68 | 323,560,070.22 | 354,234,306.99 |
| 其他应付款合计 | 1,439,213,095.49 | 1,379,797,277.71 | 1,204,116,228.05 | 1,179,810,601.52 |
| 应付股利 | 435,555,937.03 | 190,717,272.28 | 249,173,886.38 | 146,403,980.77 |
| 一年内到期的非流动负债 | 1,022,299,809.17 | 798,141,980.95 | 849,456,924.15 | 903,269,362.25 |
| 其他流动负债 | 41,919,014.51 | 40,783,681.1 | 40,054,576.8 | 44,010,153.51 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 13,726,920,913.18 | 13,389,312,998.64 | 13,504,562,959.76 | 13,225,866,187.12 |
| 非流动负债: | | | | |
| 长期借款 | 1,386,573,336.6 | 1,711,468,623.83 | 1,708,460,718.39 | 1,665,510,240.29 |
| 租赁负债 | 34,800,370.82 | 37,264,607.67 | 39,132,147.06 | 39,552,504.87 |
| 长期应付款 | 57,075,436.72 | 57,075,436.72 | 95,121,144.45 | 95,121,144.45 |
| 递延收益 | 736,413,207.67 | 711,735,983.35 | 688,337,300.53 | 701,986,555.36 |
| 递延所得税负债 | 384,138,898.46 | 385,706,985.87 | 375,171,407.97 | 377,648,829.62 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,599,001,250.27 | 2,903,251,637.44 | 2,906,222,718.4 | 2,879,819,274.59 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 16,325,922,163.45 | 16,292,564,636.08 | 16,410,785,678.16 | 16,105,685,461.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,632,257,765 | 1,632,361,067 | 1,632,361,067 | 1,632,361,067 |
| 资本公积 | 5,686,155,520.48 | 5,685,364,310.13 | 5,679,603,148.59 | 5,674,029,879.77 |
| 减:库存股 | 408,312 | 87,562,911.77 | 87,562,911.77 | 87,562,911.77 |
| 其他综合收益 | 109,478,247.92 | -146,967,646.05 | -53,013,910.16 | -22,005,085.62 |
| 盈余公积 | 489,525,634.92 | 489,525,634.92 | 489,525,634.92 | 489,525,634.92 |
| 未分配利润 | 9,951,491,183.5 | 9,717,605,105.78 | 9,842,904,735.11 | 9,357,251,379.06 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 17,868,500,039.82 | 17,290,325,560.01 | 17,503,817,763.69 | 17,043,599,963.36 |
| 少数股东权益 | 3,151,512,279.61 | 2,997,926,473.75 | 2,865,951,968 | 3,055,012,142.12 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 21,020,012,319.43 | 20,288,252,033.76 | 20,369,769,731.69 | 20,098,612,105.48 |
| 负债和股东权益合计 | 37,345,934,482.88 | 36,580,816,669.84 | 36,780,555,409.85 | 36,204,297,567.19 |
| 公告日期 | 2024-10-30 | 2024-07-27 | 2024-04-30 | 2024-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |